We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology

Publish Your Research Open Access

Looking to publish your next article?

Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve the academic research community, scientific community and practitioner community.

The below journals have various specialties in:

  • Tumor immunology, immunological biomarkers and anticancer therapies with immunotherapies
  • Thermal energy-based disease treatment, either clinical studies, biological studies or physics and engineering
  • Antibody research and development
  • Blood and lymphatic cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions
  • Cancer research and the use of preventative and integrated cancer treatment interventions to achieve improved outcomes
  • Molecular diagnosis of and targeted molecular or precision therapy for all types of cancer
  • Hepatobiliary tumors
  • Application of oncolytic viruses for the treatment of cancer
  • All topics relating to oncology, from feasibility study protocols in pancreatic cancer patients to original research assessing clinical and radiological features of pancreatic cystic lesions

Explore the links below to discover our range of open access journals and find the perfect home for your research.

OncoImmunology

An open access journal | 2019 Impact Factor 5.869

OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is a need for research that explores the combination of conventional anticancer therapies with immunotherapies. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.

VISIT JOURNAL SUBMIT

International Journal of Hyperthermia

An open access journal | 2019 Impact Factor 3.574

The International Journal of Hyperthermia provides a forum for the publication of research, perspectives and letters relating to the science, engineering, physics and clinical application of thermal energy-based disease treatment.

Disease treatment in clinical settings, including clinical trials and case studies that involve either human or animal patients will be considered for publication in the Clinical Studies category of the journal. Biological, biochemical, anatomical or physiological studies of a basic or pre-clinical nature using basic biochemical, cell, animal, or computational models will be considered for publication in the Biological Studies category of the journal. Development of technologies and strategies for energy delivery and control, with an end goal to effect specific biologic responses leading to therapeutic outcomes will be considered for publication in the Physics and Engineering category of the journal.

VISIT JOURNAL SUBMIT

mAbs

An open access journal | 2019 Impact Factor 4.634

A multi-disciplinary journal dedicated to the art and science of antibody research and development. mAbs has a strong scientific and medical focus, which strives to serve a broader readership of scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

mAbs publishes relevant and timely original research, as well as authoritative overviews, commentary and perspectives providing context for the work presented in mAbs and for key results published elsewhere.

VISIT JOURNAL SUBMIT

5 Reasons to Publish With Us

  • Get up to 8 times more views for your article by publishing open access.
  • Maximize the impact of your research by publishing in a high-quality journal.
  • Benefit from a rigorous peer review process.
  • Enjoy rapid publication.
  • It's easy to submit thanks to format-free submission.

Blood and Lymphatic Cancer: Targets and Therapy

A Dove Medical Press journal, part of Taylor & Francis Group

Blood and Lymphatic Cancer: Targets and Therapy focuses on blood and lymphatic cancer research, the identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports.

GO TO BLOOD AND LYMPHATIC CANCER

Cancer Management and Research

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 2.886

Cancer Management and Research focuses on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.

GO TO CANCER MANAGEMENT AND RESEARCH

OncoTargets and Therapy

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 3.337

OncoTargets and Therapy focuses on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

GO TO ONCOTARGETS AND THERAPY

Journal of Hepatocellular Carcinoma

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 4.655

The Journal of Hepatocellular Carcinoma offers the international community a platform for the dissemination and study of clinical, translational and basic research findings in this rapidly developing field.

Exciting developments in the areas of epidemiology, vaccination, hepatitis therapy, pathology, molecular tumor classification and prognostication, new radiological techniques, amazing new classes of targeted medical therapies and a resultant vast increase in the associated clinical trials and reports are all a vital part of focusing on hepatobiliary tumors.

GO TO HEPATOCELLULAR CARCINOMA

Oncolytic Virotherapy

A Dove Medical Press journal, part of Taylor & Francis Group

Oncolytic Virotherapy publishes original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer.

GO TO ONCOLYTIC VIROTHERAPY

AMRC Open Research

An open access publishing platform especially for the researchers they fund

The Association of Medical Research Charities (AMRC) together with its member charities, have created AMRC Open Research, a publishing platform that offers rapid author-led publication and open peer review, operates an open data policy, and publishes a range of article types. AMRC Open Research also supports the publication of other research outputs, such as posters, slides and documents. APCs are waived for a limited time.

The platform covers all topics relating to oncology, from feasibility study protocols in pancreatic cancer patients to original research assessing clinical and radiological features of pancreatic cystic lesions.

GO TO AMRC OPEN RESEARCH

Why Publish Open Access?

Publishing open access can increase the visibility of your research, helping you make an impact beyond your field.
Find out more

Dove Medical Press Author Program

Learn how you can receive fast-track processing of papers, the rapid delivery of a PDF of your paper and a 10% discount on the article publishing charge.
LEARN MORE

F1000Research

An open research publishing platform offering rapid publication of articles and other research outputs. All articles benefit from transparent peer-review and the inclusion of all source data.
GO TO F1000RESEARCH